Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

PLXPLX
10 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in PROTALIX BIOTHERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 180,381 shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $420,288 as of 2026-Q2. The position was increased (+13.2% shares). PLX represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$420,288

Current Shares

180,381

Total Value Change

+$163,452

Total Shares Change

+51,963

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
180,381
+13.2%
$420,2880.0%$2.33
27
2026-Q1
Decreased
159,311
-9.0%
$345,7050.0%$2.83
0
2025-Q4
Unchanged
175,070
0.0%
$315,1260.0%$1.74
0
2025-Q3
Unchanged
175,070
0.0%
$388,6550.0%$2.16
0
2025-Q2
New
175,070
-
$259,1040.0%$1.54
36
2024-Q2
Exited
0
-100.0%
$00.0%$1.17
0
2024-Q1
Unchanged
153,561
0.0%
$193,4870.0%$1.26
0
2023-Q4
Unchanged
153,561
0.0%
$273,3390.0%$1.78
0
2023-Q3
Increased
153,561
+19.6%
$254,9110.0%$1.66
27
2023-Q2
New
128,418
-
$256,8360.0%$2.17
32

Other major holders of PLX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used